Option Care Health (NASDAQ:OPCH) Posts Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Option Care Health (NASDAQ:OPCH) released its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.04, Briefing.com reports. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the company earned $0.21 EPS. The firm’s quarterly revenue was up 12.8% compared to the same quarter last year. Option Care Health updated its FY 2024 guidance to EPS.

Option Care Health Stock Up 1.3 %

Shares of OPCH stock traded up $0.37 during trading hours on Friday, reaching $29.66. 109,293 shares of the company’s stock were exchanged, compared to its average volume of 1,276,048. The stock’s 50 day moving average is $32.04 and its 200-day moving average is $31.50. The company has a market cap of $5.16 billion, a price-to-earnings ratio of 19.27, a P/E/G ratio of 1.65 and a beta of 1.22. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. Option Care Health has a fifty-two week low of $24.23 and a fifty-two week high of $35.74.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the acquisition, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.64% of the company’s stock.

Analyst Upgrades and Downgrades

OPCH has been the topic of several research reports. Jefferies Financial Group upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.